Editas Medicine, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-120.3M | $-97.2M | $-72.9M | $-13.7M |
| Depreciation & Amortization | — | — | — | — |
| Depreciation | $2.7M | $1.2M | $471.0K | $157.0K |
| Amortization | — | — | — | — |
| Stock-Based Compensation | $23.4M | $16.9M | $3.5M | $55.0K |
| Net Cash from Operating Activities | $-9.4M | $-50.2M | $-5.4M | $-8.7M |
| Investing Activities | ||||
| Capital Expenditures | $2.1M | $3.5M | $1.4M | $1.2M |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $-183.8M | $-3.5M | $-1.4M | — |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $154.5M | $97.2M | $139.4M | — |
| Net Change in Cash | $-38.7M | $42.1M | $132.6M | $8.6M |
| Free Cash Flow | $-11.5M | $-53.7M | $-6.9M | $-9.9M |